1-3 of 3
Rich Barron, M.S.
Close
Sort by
Journal Articles

Incidence of Febrile Neutropenia Among Patients Receiving Chemotherapy Regimens Not Classified As High-Risk in Guidelines for Myeloid Growth Factor Use: Importance of “Risk Factor Stacking”

Derek Weycker, PhD, Xiaoyan Li, PhD, Rich Barron, M.S., Hongsheng Wu, PhD, Phuong Khanh Morrow, MD, Hairong Xu, MD, PhD, Maureen Reiner, M.S., Jacob Garcia, MD, Shivani Mhatre, M.S., Gary H. Lyman, MD MPH
Journal: Blood
Blood (2014) 124 (21): 4824.
https://doi.org/10.1182/blood.V124.21.4824.4824
Published: 2014
Journal Articles

Risk and Consequences of Neutropenic Complications Among Patients with Metastatic Solid Tumors Receiving Myelosuppressive Chemotherapy

Derek Weycker, Ph.D., Xiaoyan Li, Ph.D., Alex Kartashov, Ph.D., Rich Barron, M.S., John Edelsberg, M.D., M.P.H., Hairong Xu, M.D., Ph.D., Vincent Girardi, M.S., Gary H. Lyman, M.D., M.P.H.
Journal: Blood
Blood (2013) 122 (21): 2962.
https://doi.org/10.1182/blood.V122.21.2962.2962
Published: 2013
Journal Articles

Risk of Infection Among Patients with Non-Metastatic Solid Tumors or Non-Hodgkin’s Lymphoma Receiving Myelosuppressive Chemotherapy and Antimicrobial Prophylaxis in US Clinical Practice

Derek Weycker, Ph.D., David Chandler, Ph.D., Rich Barron, M.S., Hairong Xu, M.D., Ph.D., Hongsheng Wu, Ph.D., Vincent Girardi, M.S., John Edelsberg, M.D., M.P.H., Gary H. Lyman, M.D., M.P.H.
Journal: Blood
Blood (2013) 122 (21): 1730.
https://doi.org/10.1182/blood.V122.21.1730.1730
Published: 2013